SAME-DAY TRIPLE THERAPY WITH PHOTODYNAMIC THERAPY, INTRAVITREAL DEXAMETHASONE, AND BEVACIZUMAB IN WET AGE-RELATED MACULAR DEGENERATION
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology,General Medicine
Reference23 articles.
1. Ranibizumab for neovascular age-related macular degeneration.;Rosenfeld;N Engl J Med,2006
2. Ranibizumab versus verteporfin for neovascular age-related macular degeneration.;Brown;N Engl J Med,2006
3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report.;Arch Ophthalmol,1999
4. Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.;Michels;Ophthalmology,2005
5. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.;Azab;Arch Ophthalmol,2005
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on blood-retinal barrier dysfunction;Journal of Biomedical Science;2024-05-10
2. Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches;Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic Diseases;2024
3. Current Management of Subretinal Hemorrhage in Neovascular Age-Related Macular Degeneration;Ophthalmologica;2023
4. Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan;Pharmaceutics;2021-10-14
5. Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease;Molecules;2020-10-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3